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Developing sensitivity to the psychological burden associated with skin conditions: a call 
for training 
Kerry Montgomery and Andrew Thompson 
Considering the range of physical, social and emotional consequences that can arise as a 
result of living with a skin condition it is unsurprising that dermatology patients report 
higher levels of anxiety and depression than the general population (1). With the objective 
severity of skin conditions not providing an accurate picture of psychological distress (2), 
and psychological morbidity being strongly associated with poorer quality of life,(2) it is 
disappointing that access to psychological treatment remains limited.(3) While efforts have 
been made to increase access to psychological therapies (3) there is a critical task that 
needs to take place within the dermatology clinics before patients can begin to consider the 
options of support, namely, the identification of psychological distress.  
tŚŝůĞŝŶƚĞƌĞƐƚŝŶ ?ƉƐǇĐŚŽĚĞƌŵĂƚŽůŽŐǇ ?ŚĂƐŐƌŽǁŶĞǆƉŽŶĞŶƚŝĂůůǇŝŶƌĞĐĞŶƚǇĞĂƌƐ ?ƐƚƵĚŝĞƐŚĂǀĞ
shown that despite a significant number of dermatology patients experiencing psychological 
distress, this is not identified in routine clinical practice.(4,5) Indeed, in the current issue of 
the BJD Dalgard et al. (4) present the findings of a cross ?sectional multicentre European 
study which highlights that dermatologists in Europe significantly underestimate levels of 
anxiety and depression.(4) An analysis of 3635 consultations found that the agreement 
between patients and dermatologists was poor to fair, with dermatologists failing to identify 
depression and/or anxiety in over half their patients (56% depression and 64·4% anxiety).(4) 
The underestimation of depression and anxiety was particularly evident in patients with 
chronic conditions (e.g. hand eczema and psoriasis). Dalgard et al.(4) conclude that further 
training for dermatologists is needed to increase the likelihood that patient distress will be 
identified and treated.  
These findings are sadly not new, and lend weight to an earlier study of patients with 
psoriasis,(6) in which the level of agreement between patient ?reported and clinician ?
reported anxiety and depression was low (kappa statistic 0·24 and 0·26, respectively).(6) In 
addition, when distress was actually identified in patients with psoriasis they were rarely 
offered appropriate psychological treatment.(6) Further, a number of qualitative studies 
have indicated that some patients report that distress and stigma associated with their skin 
condition is not acknowledged by clinicians.(7,8)  On a positive note, good concordance 
between patients and clinicians has been reported on quality of life measures in some 
studies;(7) however, this concordance is related to functional impact rather than affective 
distress, which clinicians are seemingly less familiar with and on occasion may consider as 
outside their remit.  
As outlined by Dalgard et al.(4) in this current issue of the BJD, the recognition of 
psychological distress is crucial given the influence of mood on the course of the skin 
condition and adherence to treatment.(4) One potentially useful strategy to assist clinicians 
in identifying psychological distress is to use brief psychological screening tools in routine 
clinical practice. Psychological screening tools (e.g. the Patient Health Questionnaire 9(9) 
and the Generalized Anxiety Disorder Questionnaire 7(10)) can assist dermatologists in 
identifying common mental health problems (e.g. anxiety and depression).(11) Screening 
tools(9,10)  provide an opportunity for dermatologists to begin a conversation with the 
patient about how they are feeling, and, if used appropriately, can assist clinicians in 
acknowledging patient distress. In addition, psychometric measures of affective distress can 
not only act as a valuable tool in indicating levels of distress but also form part of the 
assessment of risk. There is now sufficient evidence to suggest that improving mood can 
improve health outcomes for dermatology patients, and this forms an additional rationale 
for the routine assessment of distress to be included within dermatology consultations.  
Training on brief psychological assessment and management of risk may provide 
reassurance and encouragement to dermatologists; however, it is no small ask for 
dermatologists to make time within demanding and busy schedules for training. However, 
despite these legitimate barriers it is crucial that dermatologists do not miss out on an 
opportunity to support patients by identifying distress. Simply asking patients about the 
emotional impact of their skin condition can be hugely valued by and beneficial to patients. 
The growing field of psychodermatology offers an opportunity to support dermatologists 
with the necessary training and development opportunities to enhance the holistic care of 
dermatology patients. 
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